If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...

Among patients with COPD who experienced an exacerbation, the risk for cardiovascular events was highest in the following 2 weeks and stayed elevated more than 1 year after, according to study results ...

You’re more likely to find an empty bottle of Buckfast than used needles in Glasgow, even down city centre alleys concealed ...